Latest Equity Markets News

CD Private Equity Fund III reported a remarkable 726.6% jump in net profit to $18.56 million for FY25, driven by strong fair value gains and portfolio realizations. The Fund declared a $0.20 per unit distribution amid ongoing geopolitical and market challenges.

CD Private Equity Fund I reported a 43% decline in net profit for FY25 but maintained steady distributions, underpinned by key portfolio exits and a resilient US private equity market.

Hancock & Gore Limited reported a statutory net loss of $3.18 million for the half-year ended 31 March 2025, impacted by unrealised investment losses despite steady dividend income from its school uniform subsidiary. The company declared a fully franked interim dividend of 1 cent per share.

Regal Partners Limited reported a stellar 2024 with a 141% jump in average funds under management to $14.4 billion and a near tripling of net profit after tax. Strategic acquisitions and offshore expansion underpin its growth trajectory.

Toro Energy has released an updated scoping study for its Lake Maitland Uranium Project, revealing robust economics with a pre-tax NPV of A$907.9 million and a swift payback period of just 1.5 years. The study outlines a 16.3-year mine life producing uranium and vanadium with modest capital expenditure and competitive operating costs.

Assetora Limited has launched the Australian Homeowner Equity Fund, a $100 million initiative offering shared equity investments with a targeted 12% annual return, following a successful pilot with AMP Bank.

EQ Resources Limited has had its trading suspension lifted immediately following the release of a capital raising announcement, signaling renewed market activity for the mining explorer.

Whitefield Industrials Limited reported a 10% increase in core operating profit for the year ended March 2025, outperforming its benchmark with a 7.5% portfolio return and raising fully franked dividends to 10.5 cents per share.

Aspen Group has offloaded its remaining stake in Eureka Group Holdings for $27.5 million, using the proceeds to significantly reduce its net debt while maintaining its FY25 earnings guidance.

Anteris Technologies has submitted its FDA Investigational Device Exemption for the pivotal PARADIGM Trial of its DurAVR heart valve and marked a milestone of 100 patients treated, while expanding manufacturing capacity amid rising R&D costs.

US Masters Residential Property Group reported solid Q1 2025 sales of US$48.07 million and a 5% rise in net operating income, while reducing senior debt by over US$31 million despite ongoing market volatility.

Global Masters Fund Limited has appointed long-serving director Jason Pohl as its new Managing Director, signaling continuity in leadership and strategic focus.